Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
4.160
-0.100 (-2.35%)
At close: Dec 20, 2024, 4:00 PM
4.200
+0.040 (0.96%)
After-hours: Dec 20, 2024, 6:56 PM EST
Relay Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$20.11
Upside
+383.41%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $21 | Buy | Reiterates | $21 | +404.81% | Dec 12, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +332.69% | Dec 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $16 | Strong Buy | Maintains | $20 → $16 | +284.62% | Dec 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $19 → $20 | Strong Buy | Maintains | $19 → $20 | +380.77% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +356.73% | Oct 14, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $21 | Buy | Reiterates | $21 | +404.81% | Sep 17, 2024 |
| Stifel | Stifel | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +573.08% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $19 | Strong Buy | Maintains | $18 → $19 | +356.73% | Sep 16, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $20 → $24 | Strong Buy | Maintains | $20 → $24 | +476.92% | Sep 10, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $23 → $21 | Buy | Maintains | $23 → $21 | +404.81% | Sep 10, 2024 |
| Barclays | Barclays | Buy Maintains $14 → $17 | Buy | Maintains | $14 → $17 | +308.65% | Sep 10, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +380.77% | Sep 10, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $11 → $16 | Hold → Strong Buy | Upgrades | $11 → $16 | +284.62% | Sep 10, 2024 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 10, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $29 → $23 | Buy | Maintains | $29 → $23 | +452.88% | Aug 7, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $25 → $24 | Buy | Maintains | $25 → $24 | +476.92% | Aug 7, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.